Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...

Shareholders approved all proposals of the Board of Directors Severin Schwan was re-elected as Chairman of the Board of ...

FRANKFURT (Reuters) -Swiss drugmaker Roche has abandoned global targets for a more diverse workforce to avoid penalties from ...

Patients with Spinal Muscular Atrophy (SMA) are hopeful of getting access to generic versions of Roche’s patented drug ...

The Delhi High Court on Monday dismissed an interim injunction application filed by Swiss pharmaceutical giant F Hoffmann-La ...

The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy ...

“It’s really typical of what we do,” Roche said about the Worldpay deal. “Investing in a good business that had lost its way ...

Roche Holding (ROCH:CA) now has a Canadian dollar hedged Canadian Depositary Receipt, but it currently lacks liquidity. Read ...

A curling shot from the edge of the D, Nwaneri scored his trademark goal for England's under-21s - it's a skill he continues ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...

Roche, which put billions on the line a year ago across several ADC pacts, kicked off 2025 by returning to Innovent Biologics ...